湖南南新制药股份有限公司 关于提前归还临时用于补充流动资金的募集资金的公告

Group 1 - The company has cumulatively repaid RMB 100 million of temporarily supplemented working capital as of October 21, 2025 [1] - The company decided to use up to RMB 100 million of idle raised funds to temporarily supplement working capital to improve fund utilization efficiency, increase company earnings, reduce financial costs, and lower operational costs [1] - The temporary use of idle funds is limited to a period not exceeding 12 months from the date of board approval, with a commitment to return the funds to the special account if necessary [1] Group 2 - As of the announcement date, the company has fully repaid the idle raised funds used for temporary working capital [2] - The company has notified its sponsor institution and the sponsor representative about the repayment of the raised funds [2]